Material Insights · Understanding the Material World

Recombinant DNA (genetic engineering): Evolution

Timeline

The milestones from first idea to today

YearMilestone
1972Herbert Boyer and Stanley Cohen meet at a joint US and Japan meeting on bacterial DNA in Hawaii [1]
1973Their collaboration produces its first success in spring [1]
1975Scientists and lawyers meet at Asilomar, California, to manage the risks of the new method; the NIH guidelines for such research follow in 1976 [6]
1976Boyer and venture capitalist Robert Swanson found Genentech [1]
1977Boyer and Itakura have bacteria make a mammalian protein, somatostatin, for the first time [1]
1978Boyer and Keiichi Itakura prepare the human insulin gene for production in bacteria [1]
1982The FDA approves Humulin, the first biotechnology product on the market [1]

as of 2026-11-11

Lineage

The technologies it came from and the ones that came from it

Enables 5
  • Inl Insulin therapy Human insulin made by bacteria was the first recombinant medicine, approved in 1982 [1].
  • mAb Monoclonal antibodies Most therapeutic antibodies today are made in genetically engineered cells and are partly or fully human in sequence.
  • GM Genetically modified crops Genetically modified crops carry genes moved by recombinant methods.
  • PFm Precision fermentation Microbes engineered to make proteins for food and industry apply the same principle outside medicine.
  • Seq DNA sequencing Cloning DNA in bacteria gave early sequencers enough copies of a single piece to read.
Came after it
  • Cas CRISPR gene editing Gene editing changes DNA in place inside living cells instead of moving genes in carriers.

as of 2026-11-11

Sources

  1. Herbert W. Boyer and Stanley N. Cohen Science History Institute
  2. Asilomar Conference (1975) Embryo Project Encyclopedia, Arizona State University (Abigail Cave), 2024